Overview of Capecitabine Adamed
| Property | Description |
|---|---|
| Active ingredient | Capecitabine |
| Form | Film-coated tablet |
| Pharmacological class | Antineoplastic agent, Fluoropyrimidine carbamate |
| General purpose | To control the growth of rapidly dividing cells |
| Origin | Synthetic organic compound; Prodrug |
What Type of Medicine is Capecitabine Adamed?
Capecitabine Adamed, manufactured by Adamed, is a prescription-only medicine classified as an antineoplastic agent that belongs to the pharmacological class of fluoropyrimidine carbamates. This systemic drug is defined as a synthetic cytotoxic medicine and is recognized as an antimetabolite, meaning its core function is to interfere with the metabolic processes essential for cellular growth.
Its classification places it among specialized drugs clinically recognized for managing conditions characterized by the rapid and uncontrolled proliferation of abnormal cells. Its function is primarily systemic, and it is utilized as a single active ingredient product, ensuring focused therapeutic action under the trade name Capecitabine Adamed.
Composition, Form, and Origin of Capecitabine
The active substance in this preparation is Capecitabine (INN), a fully synthetic organic compound that is not derived from natural sources. The medicine is supplied for oral administration in the specific film-coated tablet dosage form, containing the active ingredient within a solid pharmaceutical base.
This oral formulation was developed to provide a therapeutic alternative to its precursor, 5-fluorouracil (5-FU), which traditionally required intravenous infusion. The tablet form allows the Capecitabine compound to be absorbed through the digestive tract for consistent systemic administration.
Why is Capecitabine Classified as a Prodrug?
Capecitabine is classified as an oral prodrug because it is administered in an inactive state and must undergo an enzymatic conversion process within the body to release the therapeutically effective substance, 5-fluorouracil.
This prodrug design is integral to the medicine’s general therapeutic purpose: to control cell proliferation. The activation is engineered to occur preferentially within tumor tissues—a concept known as tumor-selective activation—which aims to maximize the local concentration of the cytotoxic medicine where the cell growth is most rapid. This mechanism characterizes the drug's established therapeutic approach.

